Experienced in Mosaicism

Dr. Bhuvana A. Setty

Pediatric Hematology Oncology
740 Adair Ave, 
Zanesville, OH 
Experienced in Mosaicism
740 Adair Ave, 
Zanesville, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Bhuvana Setty is a Pediatric Hematologist Oncology provider in Zanesville, Ohio. Dr. Setty is rated as an Experienced provider by MediFind in the treatment of Mosaicism. Her top areas of expertise are Osteosarcoma, Adult Soft Tissue Sarcoma, Ewing Sarcoma, and Rhabdomyosarcoma.

Her clinical research consists of co-authoring 41 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Mosaicism.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in OH
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Mutual
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 2 Less Insurance Carriers -

Locations

740 Adair Ave, Zanesville, OH 43701
Other Locations
5665 Venture Dr, Dublin, OH 43017
700 Childrens Dr, Columbus, OH 43205
100 Colemans Xing, Marysville, OH 43040
7853 Pacer Dr, Delaware, OH 43015
6435 E Broad St, Columbus, OH 43213
536 S Trimble Rd, Mansfield, OH 44906
433 N Cleveland Ave, Westerville, OH 43082
4439 State Route 159, Chillicothe, OH 45601
7450 Hospital Dr Ste 100, Dublin, OH 43016

Additional Areas of Focus

Dr. Setty has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Phase II Study of Nab-Paclitaxel in Combination With Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults
Phase II Study of Nab-Paclitaxel in Combination With Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults
Enrollment Status: Active_not_recruiting
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drugs: Nab-Paclitaxel, Gemcitabine
Study Phase: Phase 2
A Phase Ib/II Study to Evaluate the Safety, Feasibility and Efficacy of Nivolumab or Nivolumab in Combination With Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
A Phase Ib/II Study to Evaluate the Safety, Feasibility and Efficacy of Nivolumab or Nivolumab in Combination With Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
Enrollment Status: Active_not_recruiting
Publish Date: August 05, 2025
Intervention Type: Drug, Procedure
Study Drugs: Nivolumab, Azacitidine
Study Phase: Phase 1
Phase 1 Trial of the LSD1 Inhibitor Seclidemstat (SP 2577) With and Without Topotecan and Cyclophosphamide in Patients With Relapsed or Refractory Ewing Sarcoma and Select Sarcomas
Phase 1 Trial of the LSD1 Inhibitor Seclidemstat (SP 2577) With and Without Topotecan and Cyclophosphamide in Patients With Relapsed or Refractory Ewing Sarcoma and Select Sarcomas
Enrollment Status: Active_not_recruiting
Publish Date: November 21, 2023
Intervention Type: Drug
Study Drugs: Seclidemstat, Cyclophosphamide, Topotecan
Study Phase: Phase 1
A Phase I Trial of Dose Escalation of Metformin in Combination With Vincristine, Irinotecan, and Temozolomide in Children With Relapsed or Refractory Solid Tumors
A Phase I Trial of Dose Escalation of Metformin in Combination With Vincristine, Irinotecan, and Temozolomide in Children With Relapsed or Refractory Solid Tumors
Enrollment Status: Completed
Publish Date: January 13, 2023
Intervention Type: Drug
Study Drugs: Vincristine, Irinotecan, Temozolomide, Metformin
Study Phase: Phase 1
A Phase 1 Safety Study of BXQ-350 Administered as a Single Agent by Intravenous Infusion in Children and Young Adults With Relapsed Solid Tumors, Including Recurrent Malignant Brain Tumors
A Phase 1 Safety Study of BXQ-350 Administered as a Single Agent by Intravenous Infusion in Children and Young Adults With Relapsed Solid Tumors, Including Recurrent Malignant Brain Tumors
Enrollment Status: Terminated
Publish Date: July 22, 2021
Intervention Type: Drug
Study Phase: Phase 1
View 4 Less Clinical Trials

41 Total Publications

Comprehensive Genomic Characterization of Congenital and Infantile Cancers Reveals High Yield of Medically Meaningful Findings.
Comprehensive Genomic Characterization of Congenital and Infantile Cancers Reveals High Yield of Medically Meaningful Findings.
Journal: JCO precision oncology
Published: June 06, 2025
Similar Doctors
Experienced in Mosaicism
Dr. Melissa Rose
Pediatric Hematology Oncology
Experienced in Mosaicism
Dr. Melissa Rose
Pediatric Hematology Oncology

Pediatric Academic Association, Inc.

700 Children's Dr, 
Columbus, OH 
 (51.2 miles away)
614-722-4579
Languages Spoken:
English
See accepted insurances

Melissa Rose is a Pediatric Hematologist Oncology provider in Columbus, Ohio. Dr. Rose is rated as an Advanced provider by MediFind in the treatment of Mosaicism. Her top areas of expertise are Pyruvate Kinase Deficiency, Acquired Amegakaryocytic Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Splenectomy, and Tissue Biopsy.

Experienced in Mosaicism
Dr. Rajinder S. Bajwa
Pediatric Hematology Oncology
Experienced in Mosaicism
Dr. Rajinder S. Bajwa
Pediatric Hematology Oncology
536 S Trimble Rd, 
Mansfield, OH 
 (61.6 miles away)
614-722-6200
Languages Spoken:
English
See accepted insurances

Rajinder Bajwa is a Pediatric Hematologist Oncology provider in Mansfield, Ohio. Dr. Bajwa is rated as an Advanced provider by MediFind in the treatment of Mosaicism. His top areas of expertise are Hepatic Venoocclusive Disease with Immunodeficiency, Graft Versus Host Disease (GvHD), Aplastic Anemia, Anemia, and Bone Marrow Transplant.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Setty's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile